Therefore, we hypothesized that Pro-Se may potentially show beneficial effects by decreasing the expression of NF-κB. As shown in Figure 4, NF-κB expression in the saline group was significantly higher than that in the control group (P < 0.01), and Pro-Se treatment significantly suppressed asthma-induced NF-κB expression. Here, NFKB1 is linked to asthma.